Published online before print August 4, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1
* Goldman School of Dental Medicine, Department of Periodontology and Oral Biology,
Department of Statistics and Mathematics,
Medical Center, Department of Endocrinology, and
¶ School of Medicine, Department of Biochemistry, Boston University, Massachusetts; and
Brigham and Women’s Hospital and Harvard Medical School, Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Boston, Massachusetts
2Correspondence: Department of Periodontology and Oral Biology, Boston University, Goldman School of Dental Medicine, 100 East Newton Street G-107, Boston MA 02118. E-mail: tvandyke{at}bu.edu
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Key Words: signal transduction • diabetes
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Stimulated neutrophils produce large quantities of superoxide (O2–) and hydrogen peroxide, which are major components of the oxygen-dependent, antimicrobial arsenal of these cells [3 ]. The reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, which catalyzes the generation of O2– and peroxide, is dormant/dissociated in unstimulated cells and consists of membrane-bound (cytochrome b558), cytoskeletal-associated (p67-phox), and cytoplasmic proteins (p47-phox, Rac). Upon stimulation, the oxidase is assembled/activated on the inner surface of the plasmalemma and phagosomal membrane [3 , 4 ]. p47-phox is an adaptor protein that facilitates assembly of the oxidase after undergoing phosphorylation on multiple serine residues in its C-terminal region [5 ]. Protein kinase C (PKC) catalyzes the phosphorylation of p47-phox after activation by its natural activator sn-1,2-diacylglycerol (DAG) or the tumor promoter phorbol 12-myristate 13-acetate (PMA) [6 , 7 ]. PMA binds to the DAG site on PKC [7 ]. Phagocytic leukocytes from diabetic patients release enhanced amounts of O2–/peroxide when compared with normal cells [8 9 10 11 ]. The biochemical mechanism(s) responsible for this is not known.
Hyperglycemia affects cells through a variety of mechanisms [12 ]. For example, increased concentrations of glucose promote de novo synthesis of DAG in cells through the glycolytic/glycerol-3-phosphate acyltransferase pathway. The resulting increases in DAG trigger activation of PKC with physiological consequences (for review, see ref. [13 ]). In addition, numerous proteins undergo nonenzymatic glycosylation in a hyperglycemic environment to form advanced glycation end products (AGE), which accumulate in diabetic plasma and tissues (e.g., ref. [14 ]). A well-characterized receptor for AGE is present on monocytes, macrophages, and neutrophils [15 , 16 ]. AGE alone triggers minimal O2–/peroxide production by neutrophils but markedly increases the production of these reactive oxygen species upon subsequent stimulation of the cells with the chemoattractant N-formyl-Met-Leu-Phe (fMLP) [16 17 18 ]. AGE have been implicated in susceptibility oral infections, exaggerated inflammatory responses, and destruction of alveolar bone, which accompanies diabetes [19 , 20 ].
Chronic periodontitis is the most common type of periodontal disease and results from extension of the inflammatory process initiated by bacteria in the gingiva to the supporting periodontal tissues. A reciprocal relationship exists between diabetes and periodontal disease [21 22 23 24 ]. Periodontal infections, like other infections, have a significant impact on diabetic control [21 , 22 ]. Conversely, diabetes is a significant risk factor for the development of periodontal disease and aggravates the severity of periodontal infections [23 ]. Factors that increase the severity of inflammatory diseases, such as altered neutrophil function, have been associated with the pathogenesis of diabetes [24 ]. The comorbidity of these two inflammatory diseases suggests that there are common elements of pathogenesis related to risk for both conditions.
In this paper, we report a novel mechanism of neutrophil priming, where elevated PKC activity results in increased phosphorylation of p47-phox and O2– release. Moderate or poor glycemic control in diabetic patients raises PKC protein levels and activity causing neutrophil priming. The increased inflammation and oxidative stress are consistent with increased risk for inflammatory complications of diabetes, including periodontitis.
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
200 mg/dl (11.1 mmol/l); fasting (no caloric intake for at least 8 h) plasma-glucose levels 120 mg/dl (6.7 mmol/l); and plasma-glucose levels 200 mg/dl (11.1 mmol/l) during an oral glucose-tolerance test. Nondiabetic, healthy and chronic periodontitis subjects were recruited from the patient pool of the Clinical Research Center at Boston University School of Dental Medicine, a unit of the General Clinical Research Center at Boston University Medical Center. Diabetic subjects signed a release form for their medical records prior to baseline. Patients were grouped by glycemic control, as defined by the American Diabetes Association, based on the amount of glycated hemoglobin (HbA1c) in erythrocytes, and HbA1c <7.0%: good control; HbA1c 7.0–8.0%: moderate control; and HbA1c >8.0%: poor control requiring treatment [25 , 26 ].
At baseline, the medical and dental status of subjects was reviewed and recorded. All diabetic subjects were at least 21 years of age, able to give written, informed consent, did not have any other systemic disease in addition to diabetes, and had a minimum of 16 of their natural teeth excluding their third molars. Nondiabetic, healthy subjects, meeting the same inclusion criteria, were included as controls. Individuals with active infectious diseases (e.g., hepatitis, AIDS, tuberculosis), chronically treated with medications known to affect periodontal tissues (phenytoin, cyclosporin-A, or calcium channel blockers) and females who were lactating or pregnant, were excluded.
Periodontal status was evaluated based on radiographic findings (bone level as a percentage of total tooth length) and clinical attachment loss. The severity of periodontitis was assessed by measuring pocket depth; pockets 5 mm but less than 7 mm on two nonadjacent teeth were defined as moderate, and pockets 7 mm on two nonadjacent teeth were defined as severe [27
]. The demographics and the characteristics of the DM patients and healthy controls are described in Table 1
.
|
View this table: [in a new window] |
Table 1. Demographic Data of Study Subjects
|
95% viability, as determined by trypan blue exclusion.
O2– release
O2–release was monitored spectrophotometrically at 37°C by measuring O2–dismutase-inhibitable reduction of ferricytochrome c at 550 nm [29
]. Assays were carried out in 96-well microtiter plates with flat-bottomed wells (Linbro type, Flow Laboratories). Five separate samples were used for each condition. Control wells contained all of the components of the assay mixture plus O2–dismutase (20 U/ml) to correct for ferricytochrome c reduction by agents other than O2–. Cells (1.5x105) were suspended in PBS (200 µl/well) and stimulated by the addition of PMA (300 nM) or fMLP (1.0 µM) and the absorbance (optical density) at 550 nm, recorded in a Vmax kinetic microplate reader (Molecular Devices, Sunnyvale, CA). O2–release was measured under conditions of linearity with respect to time and cell number and is expressed as nmole O2–/min/105 PMNs.
Subfractionation of neutrophils
Subfractionation of neutrophils was performed at 4°C as described by Wolfson and colleagues [30
] with minor modifications. Neutrophils (10x106 cells/ml) were suspended in Hanks’ balanced salt solution (HBSS; 5.37 mM KCl, 0.44 mM KH2PO4, 136.89 mM NaCl, 0.34 mM Na2HPO4, 4.17 mM NaHCO3) without magnesium and calcium, preincubated for 10 min at 37°C, and then treated with PMA [300 nM final concentration in 0.10% dimethyl sulfoxide (DMSO)] or 0.10% DMSO alone for 10 min. Assays were terminated by immersing the reaction tubes in an ice bath for 5 min. Cells were then washed twice with HBSS without magnesium and calcium, suspended at 5 x 107 cells/ml in extraction buffer [20 mM Tris·HCl, pH 7.5, 10 mM EGTA, 2.0 mM EDTA, 1.0 mM phenylmethylsulfonyl fluoride, 50 mM 2-mercaptoethanol (2-ME), 20 U leupeptin/ml, and 0.0122 U aprotinin/ml], and sonicated at 15 W for 15 s. An aliquot of the lysate was saved, and the remaining sonicate was centrifuged at 100,000 g for 60 min. The supernatant fluid was collected and is referred to as the cytosol-rich or soluble fraction. The pellet was resuspended to the original volume in extraction buffer, sonicated again at 15 W for 15 S, and incubated for 1 h at 4°C in the presence of 0.30% (final concentration) Triton X-100. The resulting suspension is referred to as the membrane-rich fraction.
PKC assay
Calcium-dependent PKC activity was assayed as described previously [31
, 32
] with minor modifications. This enzyme was assayed by measuring the transfer of 32P from [
-32P]adenosine 5'-triphosphate (ATP) into histone III-S at 30°C. The standard assay mixture contained 25 mM Tris·HCl, pH 7.4, 10 mM MgCl2, 0.50 mM CaCl2, 0.20 mg/ml histone type III-S, 20 µg/ml diolein (DAG), and 50 µg/ml phosphatidylserine (PS). The 100,000 g soluble and membrane fractions were used as the source of PKC, and the reactions were initiated by the addition of 50 µM [-32P]ATP (1.0 µCi). Reactions were terminated by the addition trichloroacetic acid (TCA) to a final volume of 25%. The resulting precipitates were collected by vacuum filtration on polycarbonate filters (type cellulase acetate, 0.45 µm; Costar, Cambridge, MA) and washed three times with 5.0% TCA. After drying, the amount of radioactivity on the filters was quantified by ß-liquid scintillation counting (LKB, Bromma, Sweden). Assays were performed in the presence of Ca2+ alone, DAG/PS alone, and Ca2+/DAG/PS, and the values for Ca2+ and DAG/PS alone were subtracted from the value for Ca2+/DAG/PS. Activity measured under these conditions was linear from 1.0 to 7.0 min and was directly proportional to the quantity of the "cell fractions" present in the assay between 0.75 x 105 and 2.25 x 105 cell equivalents. Activity is expressed as picomoles of 32P incorporated per minute per 107 cells.
Western blot
Cell lysates (60 µg/ml) were placed in sodium dodecyl sulfate (SDS) sample buffer [62.5 mM Tris-HCl, pH 6.8, 2% w/v SDS, 10% glycerol, 50 mM dithiothreitol, 0.01% w/v bromophenol blue] and boiled for 5 min. Samples and standards (Bio-Rad, Hercules, CA) were loaded on 10% SDS-polyacrylamide gel electrophoresis (PAGE) acrylamide gels. Proteins were transferred from the gel to a polyvinylidene difluoride membrane, and the membrane was incubated with p47-phox antibody (1:200) overnight at 4°C in 20 mM Tris–HCl (pH 7.5) containing 250 mM NaCl, 0.10% (v/v) Tween 20, and 5.0% (w/v) bovine serum albumin. The membrane was washed three times (10 min/wash) with 20 mM Tris–HC1, pH 7.4, containing 150 mM NaCl and 0.01% (v/v) Tween 20 (TBST) and then incubated with the second antibody (donkey anti-goat immunoglobulin G-horseradish peroxidase conjugate; 1:3000) in TBST for 1 h at room temperature. Membranes were again washed three times in TBST. Bands were visualized after incubation of membranes for 5 min at room temperature in a luminol-enhanced chemiluminescence detection system (Pierce, Rockford, IL) followed by autoradiography.
To assess the relevant isoforms of PKC being activated, neutrophils were incubated with GF109203X {2-[1-(3-dimethylamino-propyl)indol-3-yl]-3-(1H-indol-3-yl)maleimide; also known as bisindolylmaleimide I or Gö 6850}, a potent and selective inhibitor of PKC-
, -ß1, and -ß2 at 5 µM for 15 min, or staurosporine, a nonspecific and potent inhibitor of kinases including PKC, PKA, and PKG at 0.1 µM for 10 min [33
34
35
]. O2–generation postincubation was assayed as described above.
Measurement of diglyceride
Diglyceride was extracted from neutrophils by the method of Bligh and Dyer [36
] and converted stoichiometrically to [32P]phosphatidate ([32P]PA) by incubation with [-32P]ATP and Escherichia coli diglyceride kinase [37
]. The resulting [32P]PA was isolated by thin-layer chromatography, visualized by autoradiography, scraped from the plate, and quantified by scintillation counting [37
].
Immunoblotting/detection of phosphorylated p47-phox in neutrophils
Phosphorylation of p47-phox in stimulated neutrophils was monitored by Western blotting with a phosphospecific antibody [pAb; pPKC (S) Ab] obtained from Cell Signaling Technology (Beverly, MA) [38
]. The preferred sequence recognized by this pAb is phospho-Ser flanked by Lys or Arg at the –2 and +2 positions and with a hydrophobic residue at the +1 position. The specificity of this pAb is not rigid, and motifs similar to the preferred sequence are also recognized by this pAb. A mouse monoclonal antibody (mAb) raised against nonphosphorylated, recombinant p47-phox was a gift from Dr. Paul Heyworth (Scripps Research Center, La Jolla, CA). Neutrophils (1.9x106/ml) were stimulated in disposable, 1-cm plastic cuvettes at 37°C. The standard assay mixture consisted of a modified Dulbecco’s PBS medium (135 mM NaCl, 2.7 mM KCl, 16.2 mM Na2PO4, 1.47 mM KH2PO4, 0.90 mM CaCl2, and 0.50 mM MgCl2, pH 7.35) containing 7.5 mM D-glucose. Cells were incubated in this medium for 10.0 min prior to stimulation with 300 nM PMA. At the appropriate time-points, the cells were lysed rapidly by adding 0.25 ml of 5x concentrated "solubilization buffer" (SDS-B) to 1.0 ml of the reaction mixture, and the samples were boiled for 4.0 min. The final composition of SDS-B after mixing was 2.3% (w/v) SDS, 62.5 mM Tris-HCl (pH 6.8), 5.0 mM EDTA, 10.0% (v/v) glycerol, 5.0% (v/v) 2-ME, and 0.002% (w/v) bromophenol blue. Aliquots of these samples were separated by SDS-PAGE (35 µg/lane) on 9.0% (v/v) polyacrylamide slab gels and transferred electrophoretically to Immobilon P-membranes. Protein phosphorylation was assayed by Western blotting with the pPKC (S) Ab. Membranes were incubated with the pAb (ca., 1:1000 dilution) overnight at 4°C. Phosphorylated proteins were visualized with a luminol-enhanced chemiluminescence detection system (Pierce). Conditions for Western blotting are detailed elsewhere [38
]. At the end of these experiments, the immunodetection system and the bound antibodies were removed from the blot by incubating the membrane with ImmunoPure elution buffer (Pierce) for 30–60 min at room temperature followed by two washes in TBST. The blots were then stained with the mAb to p47-phox, which recognized the phosphorylated and nonphosphorylated forms of this protein.
Statistical analysis
Results are expressed as mean ± SE. Analysis of covariance (ANCOVA) adjusting for age was used with the Statistical Analysis System. Multiple comparison procedures were used for group pairs, and comparison was controlling for overall type I error. Means were adjusted for possible confounding factors of age, smoking, and gender. Difference in the age-adjusted means between groups was considered significant for a P value less than 0.05. Correlation analysis was conducted using Spearman’s 
test. We performed a trend analysis to examine whether the mean hemoglobin level increases as the severity of periodontitis increases.
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
 View larger version (26K): [in a new window] |
Figure 1. Neutrophils from diabetic subjects generate more O2– anion. Diabetic individuals were grouped into three categories based on glycemic control as defined by the American Diabetes Association. Rates of O2–release by neutrophils obtained from healthy individuals and patients with good (HbA1c<7.0%), moderate (HbA1c between 7.0% and 8.0%), and poor (HbA1c >8.0%) glycemic control are presented. Cells were stimulated with 1.0 µM fMLP or 300 nM PMA, and O2–release was measured as described in Materials and Methods. Neutrophils from diabetic patients with moderate and poor glycemic control exhibited greater release of O2–than neutrophils from patients with well-controlled diabetes or healthy individuals. (*, P<0.05, compared with healthy; #, P<0.05, compared with well-controlled diabetics.)
|
 View larger version (26K): [in a new window] |
Figure 2. O2–release by diabetic neutrophils is not insulin-dependent. Cells were stimulated with 1.0 µM fMLP or 300 nM PMA, and O2– release was measured as described in Materials and Methods. No differences in O2–release were observed between patients with type 1 and type 2 DM. These data include patients with good, moderate, and poor glycemic control.
|
 View larger version (35K): [in a new window] |
Figure 3. Ca2+-dependent PKC activity is increased in membranes of neutrophils from diabetic patients. Ca2+-dependent PKC activity was measured under optimal conditions in the 100,000 g soluble and membrane fractions of unstimulated (A) and stimulated neutrophils (B), which were stimulated with PMA (300 nM) for 10.0 min. (A) Unstimulated neutrophils from diabetic patients with moderate and poor glycemic control exhibited significantly higher PKC activity than neutrophils from healthy subjects and patients with well-controlled diabetes (#, P<0.05). (B) Redistribution of PKC activity from the soluble to the membrane fraction in PMA-stimulated neutrophils was significantly greater in cells from diabetic patients compared with healthy individuals, independent of glycemic control (*, P<0.05). Procedures for cell fractionation and the assaying Ca2+-dependent PKC activity are described in Materials and Methods.
|
To ascertain if the increased PKC activity resulted from activation of a static precursor pool or if there was an increase on total PKC protein that was being activated, total PKC was evaluated by Western blot. Figure 4 reveals that there is an increase in the total PKC pool with decreasing diabetic control.
 View larger version (35K): [in a new window] |
Figure 4. Total neutrophil PKC increases with poor glycemic control. Neutrophils were evaluated by Western blotting using an affinity-purified polyclonal antibody specific for PKC (inset). Band density was quantified by densitometry. The data reveal that PKC total protein is increased in diabetics, and the increase is associated with glycemic control.
|
, -ß1, and -ß2, or staurosporine, a nonspecific and potent inhibitor of kinases, revealed that GF109203X returned O2–generation by primed diabetic neutrophils to normal levels, suggesting that the PKC-/ß isoforms are being up-regulated in diabetes (Fig. 5
).
 View larger version (27K): [in a new window] |
Figure 5. Inhibition of PKC suppresses O2– generation in healthy individuals and diabetic patients. Peripheral blood neutrophils were treated with GF109203X, a selective inhibitor of PKC-, -ß1, and -ß2 at 5 µM for 15 min, or staurosporine, a nonspecific, potent inhibitor of kinases at 0.1 µM for 10 min. O2–generation was then analyzed in response to fMLP (1.0 µM). GF109203X inhibited PKC activation  50% more in diabetics compared with healthy individuals (*, P<0.05). Staurosporine inhibition was less effective, and there was no difference between patients and healthy control individuals. The effect of GF109203X on diabetic neutrophils was also significantly higher than the staurosporine-treated cells (#, P<0.05).
|
 View larger version (12K): [in a new window] |
Figure 6. Diglycerides in neutrophils from diabetic patients and healthy, nondiabetic individuals. Diglyceride was measured in neutrophils from healthy individuals and diabetic patients before and after cell stimulation with 1.0 µM fMLP for 5.0 min. Unstimulated neutrophils from diabetic patients contained significantly more diglyceride than unstimulated neutrophils from healthy individuals (P<0.01). The diabetic patients used in these studies included individuals with good, moderate, and poor glycemic control. Diglyceride was measured as described in Materials and Methods.
|
, ßI, ßII, ) [40
]. Although the magnitude of the response varied, four of the five patients exhibited enhanced phosphorylation of p47-phox at all time-points examined when compared with time-matched control cells (Fig. 7)
. The fifth patient exhibited a phosphorylation pattern similar to the control/normal neutrophils (data not shown). Western blotting with an antibody that recognizes phosphorylated and nonphosphorylated p47-phox indicated that the amounts of this protein were similar in neutrophils from the patients and controls (Fig. 7
, lanes i and j). Immunoprecipitation studies have positively identified the band shown in Figure 7
as p47-phox [38
].
 View larger version (33K): [in a new window] |
Figure 7. Phosphorylation of p47-phox in normal neutrophils and neutrophils from diabetic patients with poor glycemic control monitored by Western blotting with a pAb. Neutrophils from healthy individuals (HC; lanes a–d) and diabetes patients with poor glycemic control (DM-PC; lanes e–h) were stimulated with 300 nM PMA for the time periods indicated, and phosphorylation of p47-phox was measured by Western blotting with the pPKC (S) Ab. Neutrophils from the patients and healthy individuals were isolated and stimulated simultaneously. Lanes i and j show the total amount of p47-phox in these subjects monitored with an antibody that recognizes the phosphorylated and nonphosphorylated forms of this protein. Data from four different patients are presented. Conditions for cell stimulation and Western blotting are provided in Materials and Methods.
|
 View larger version (19K): [in a new window] |
Figure 8. The severity of periodontitis is increased with poor glycemic control on diabetes. The mean level of HbA1c increases significantly as the severity of periodontitis increases (r=0.71, P<0.001). The broken line indicates the threshold for "strict glycemic control" as the "treatment goal" recommended by American Diabetes Association. Diabetics with severe periodontitis have significantly higher HbA1c percent levels compared with diabetics with no periodontal disease (DM-NP; *, P<0.001) and those with moderate periodontitis (#, P<0.005). The severity of periodontitis was assessed by measuring "pocket depth" on two nonadjacent teeth as described in Materials and Methods. Chronic periodontitis alone did not lead to increased O2– production (data not shown). Data presented here were adjusted for the duration of diabetes.
|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
Certain biologically active lipids (e.g., platelet-activating factor; 5-hydroxyeicosatetraenoic acid), microbial products (lipopolysaccharide), cytokines (tumor necrosis factor ; granulocyte macrophage-colony stimulating factor), calcium ionophores, and AGE prime neutrophils to produce increased O2– in response to chemoattractants and suboptimal amounts of PMA [16
17
18
, 41
42
43
44
45
46
]. These agents enhance O2– through a variety of inter-related mechanisms, which include promoting association of PKC with the plasmalemma, increased generation of lipid-derived second messenger molecules [phosphoinositide-3 kinase, phospholipase A2 (PLA2) and PLD, sphingosine 1-kinase], and/or preassembly of the oxidase on the plasmalemma [18
, 41
42
43
44
45
46
]. To our knowledge, neutrophils from diabetic patients with moderate or poor glycemic control represent the first example where these cells are primed to respond to an optimal amount of PMA or fMLP and contain increased PKC activity in the cytosolic and membrane fractions. PMA binds to and activates PKC [7
], which in turn, catalyzes the phosphorylation of p47-phox on multiple sites (e.g., ref. [6
]). p47-phox forms a stable complex with the ß-isoforms of PKC, and this interaction promotes phosphorylation of this substrate [47
, 48
]. The rate of O2– release from PMA-stimulated neutrophils is proportional to the amount of phosphorylated p47-phox [7
, 49
]. Data in the present study support a mechanism in which elevated PKC activity in diabetic neutrophils results in enhanced O2– release.
Hyperglycemia promotes de novo synthesis of diglyceride in various cells, which can trigger an increased translocation/redistribution of PKC to the membrane [12
, 13
]. Neutrophils from diabetic subjects contain elevated diglycerides (Fig. 6)
, which can explain the increases in membrane-bound PKC activity found in these cells (Fig. 3)
. However, an increase in translocation cannot explain the enhanced activity of soluble PKC, which was also observed in neutrophils from diabetic patients with moderate or poor glycemic control (Fig. 3)
. Data from Western blots indicate that these increases in PKC activity are a result of an increased content of enzyme protein. As the antibodies available are specific to PKC-, -ß1, and -ß2, the data are consistent with previous reports suggesting an increase in PKC-ß1 activity in diabetes. This was confirmed using /ß-specific inhibitors of PKC. Hyperglycemia can increase PKC activity in cultured THP-1 cells and in human monocytes in vivo [50
, 51
]. Increased PKC in diabetic neutrophils is consistent with our observation that the priming of these cells is stable and was not reversible simply by washing the cells. In contrast, washing might be expected to reverse priming events that are dependent solely on the constant occupation of certain receptors [17
].
The NADPH-oxidase complex and its homologs have been identified in a variety of nonmyeloid cells/tissues, where they participate in a number of diverse physiological and pathological processes that include insulin signaling, blood vessel tonicity, and atherogenesis [52 53 54 ]. Hyperglycemia/chronic activation of PKC triggers activation of the oxidase, and the resulting increase in O2–/H2O2 has been implicated in the atherosclerosis and nephropathy that accompany diabetes [55 , 56 ]. Thus, understanding how the NADPH oxidase is altered in neutrophils by diabetes may provide important insights into the dysregulation of this enzyme complex in nonmyeloid cells.
An interesting finding with respect to the clinical management of the diabetic patient is the relationship/correlation between elevated HbA1c, enhanced O2– release by neutrophils (Fig. 1) , and the severity of periodontitis (Fig. 8) . It is interesting that there were no differences amongst the diabetic groups in other laboratory values, such as mean cholesterol, triglyceride, or high-density lipoprotein (Table 1) . This finding is consistent with previous studies suggesting a reciprocal relationship between diabetes and periodontal disease [21 , 22 , 24 , 57 ]. O2–and/or H2O2 have been implicated in the destruction of periodontal tissues, and periodontitis has been characterized as an inflammatory disease [57 ]. Moreover, the increased risk for periodontitis in diabetics and the increased severity of diabetes in patients with periodontitis suggest a common inflammatory pathway leading to increased severity of both diseases. We have recently reported that lipoxins and their stable analogs, which block neutrophil chemotaxis and O2– production in vitro, dramatically reduce periodontitis in a rabbit model [58 ]. A selective antagonist of PKC-ß can prevent some of the complications of type 2 diabetes in a rodent model [59 ], and clinical studies are now under way to evaluate the long-term usefulness of these compounds in humans [13 ]. It will be important to determine if treatments targeted at limiting the inflammatory response reduce the severity of periodontitis in diabetics without compromising the antimicrobial properties of phagocytic leukocytes in these patients.
Received October 12, 2004; revised June 28, 2005; accepted June 30, 2005.
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONREFERENCES |
|---|
, ß II, 
, and 
: effect on binding to p22phox and on NADPH oxidase activation Biochemistry 41,7743-7750[CrossRef][Medline]-tocopherol supplementation Circulation 102,191-196-Tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C- Diabetes 51,3049-3054This article has been cited by other articles:
 |
|
 |
|
  S. Ayilavarapu, A. Kantarci, G. Fredman, O. Turkoglu, K. Omori, H. Liu, T. Iwata, M. Yagi, H. Hasturk, and T. E. Van Dyke Diabetes-Induced Oxidative Stress Is Mediated by Ca2+-Independent Phospholipase A2 in Neutrophils J. Immunol., February 1, 2010; 184(3): 1507 - 1515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species Physiol Rev, January 1, 2009; 89(1): 27 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Omori, T. Ohira, Y. Uchida, S. Ayilavarapu, E. L. Batista Jr., M. Yagi, T. Iwata, H. Liu, H. Hasturk, A. Kantarci, et al. Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase J. Leukoc. Biol., July 1, 2008; 84(1): 292 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Qvarnstrom, S. Janket, J.A. Jones, P. Nuutinen, A.E. Baird, M.E. Nunn, T.E. Van Dyke, and J.H. Meurman Salivary Lysozyme and Prevalent Hypertension Journal of Dental Research, May 1, 2008; 87(5): 480 - 484. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus J. Immunol., July 1, 2007; 179(1): 647 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gyurko, C. C. Siqueira, N. Caldon, L. Gao, A. Kantarci, and T. E. Van Dyke Chronic Hyperglycemia Predisposes to Exaggerated Inflammatory Response and Leukocyte Dysfunction in Akita Mice J. Immunol., November 15, 2006; 177(10): 7250 - 7256. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
